𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanoma

✍ Scribed by Sznol, Mario; Dutcher, Janice P.; Atkins, Michael B.; Rayner, Anthony R.A.; Margolin, Kim A.; Gaynor, Ellen R.; Weiss, Geoffrey R.; Aronson, Fred; Parkinson, David R.; Hawkins, Michael J.

Book ID
125432618
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
730 KB
Volume
16
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I trial of subcutaneous recombinan
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma
✍ Omar Eton; Michael G. Rosenblum; Sewa S. Legha; Wehei Zhang; Mary Jo East; Agop πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 3 views

## Abstract ## BACKGROUND Interleukin‐2 (IL‐2) has activity in metastatic melanoma when given in high doses by the intravenous (IV) route, but its side effects and effectiveness when given in intermediate to high doses by the subcutaneous (SC) route have not been studied adequately. This study sou